A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PR3 / anti-proteinase 3

[Related PubMed/MEDLINE]
Total Number of Papers: 49
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PR3  (>> Co-occurring Abbreviation)
Long Form:   anti-proteinase 3
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Two Cases of Vasculitis with Renal Vein Thrombosis. AAV, MPO
2020 Pro-inflammatory Stimulation of Monocytes by ANCA Is Linked to Changes in Cellular Metabolism. ANCA, MPO
2020 The pathogenesis and treatment in antineutrophil cytoplasmic antibody associated vasculitis. AAV, ANCA, MPO
2019 Anemia Combined Significantly Increased High-Sensitivity C Reactive Protein and Lung Lesions Lead to the Diagnosis of Granulomatosis with Polyangiitis Proven by Lung Biopsy and Anti-neutrophil Cytoplasmic Antibody Test. ANCA
2019 Clinical Characteristics of Hydralazine-induced Lupus. ANA, anti-dsDNA, MPO
2019 Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis. ANCA, ENT, GPA, MPA, MPO, SVV
2019 [The 469th case: multiple cutaneous abscesses, pelvic mass, and lung cavities]. ---
2018 Antineutrophil cytoplasmic antibodies in Chinese patients with tuberculosis. ANCAs, MPO, pANCA
2018 Methimazole-Induced Pauci-Immune Glomerulonephritis and Anti-Phospholipid Syndrome: An Important Association to Be Aware of. APS, MMI
10  2017 Analysis of Antineutrophil Cytoplasm Antibody from 118 730 Patients in Tertiary Hospitals in Jiangxi Province, China. ANCA, IIF, MPO, TCM
11  2017 Successful treatment of granulomatosis with polyangiitis with hydropneumothorax using corticosteroids and immunosuppressant. c-ANCA, CT, GPA
12  2016 The Diagnostic Value of Alpha-1-Antitrypsin Phenotype in Patients with Granulomatosis with Polyangiitis. A1AT, A1ATD, BVAS, IEF
13  2015 Cocaine-induced delayed recurrent vasculitis: a 4-year follow-up. MPO
14  2015 There is no benefit in routinely monitoring ANCA titres in patients with granulomatosis with polyangiitis. ANCA, GPA, NPV
15  2014 A dual-fixed neutrophil substrate improves interpretation of antineutrophil cytoplasmic antibodies by indirect immunofluorescence. ANCA, ELISA, IIF
16  2012 Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. ---
17  2012 Culture-negative subacute bacterial endocarditis masquerades as granulomatosis with polyangiitis (Wegener's granulomatosis) involving both the kidney and lung. C-ANCA, SBE
18  2012 Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. CIAs, GPA, MPA, MPO
19  2012 Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis. AAV, ANCA, PE
20  2012 Routine use of Zenit RA, a novel chemiluminescent immunoanalyzer in autoimmune disease diagnosis. aB2GP1, aCL, CCP, dsDNA, ENA, MPO
21  2012 The effect of anti-tuberculosis treatment on levels of anti-phospholipid and anti-neutrophil cytoplasmatic antibodies in patients with active tuberculosis. aCL, ANCA, anti-beta2GPI, BPI, MPO, TB
22  2011 Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. anti-GBM, MPO
23  2011 Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis. ANCA, MPO, sFlt1
24  2011 Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective. RIT, WG
25  2009 A novel enzyme-linked immunosorbent assay method for the detection of human neutrophil antigen-2a antibodies. ELISA, HNA, MAIGA, rHNA-2a
26  2009 Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models. AASV, LAMP-2, MPO
27  2008 Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis. ANCA, ANCA, IgG, MPO
28  2008 Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus. MPO, SLE
29  2007 Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. GC
30  2007 Serum concentration of interleukin-18 is up-regulated in patients with ANCA-associated vasculitis. ASV, MPO
31  2006 Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. CI, RR
32  2005 Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. aCL, AHA, alpha1 AT, ANA, ANCA, ATD, CR-P, ISV, LLD, MPA, MPO, TRF, WG
33  2005 Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modify their apoptosis. ANCA, IGEM, LM, PMNs, TEM
34  2003 Monocyte activation and relationship to anti-proteinase 3 in acute vasculitis. ANCA, IL, TNFR1
35  2002 Atypical manifestation of a cytoplasmic antineutrophil cytoplasmic antibody (PR3-ANCA)-associated vasculitis with involvement of aortic intima and parietal endocardium. ANCAs
36  2002 Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases? ANA, anti-dsDNA, CTD, ELISA, RA, sICAM-1
37  2001 Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. ANCA, ELISA, IL-8, MPO, PMNs
38  2000 Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA). C-ANCA, WG
39  2000 Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). aCL, ANCA, beta2GPI, IIF, MPO, PCR
40  2000 Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study. ANCA, MPO
41  2000 What you should know about PR3-ANCA. Structural aspects of antibodies to proteinase 3 (PR3). ANCA, HLA
42  1999 Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane. HUVEC, RT-PCR
43  1998 Clinical spectrum associated with positive ANCA titres in 94 consecutive patients: is there a relation with PR-3 negative c-ANCA and hypergammaglobulinaemia? c-ANCAs, PPV, WG
44  1998 Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease. c-ANCA, ELISA, pANCA, PTU, WG
45  1995 Detection of anti-neutrophil cytoplasmic antibodies by immunoprecipitation. IF, IP, MPO, WG
46  1995 Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies. beta-ME, MPO, WG
47  1995 Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. ANCA, IVIG
48  1994 Autoantibody associations with MHC class II antigens in scleroderma and autoimmune vasculitis. ACA, ANCA, MPO
49  1993 ["Idiopathic" extracapillary glomerulonephritides without immune deposits are vascularitides: clinical and serologic analysis]. GN, MPO, WG